Compounds and compositions as protein kinase inhibitors

Details Compounds and compositions as protein kinase inhibitors Compounds and compositions as protein kinase inhibitors

2005-06-23

2008-09-09

Berch, Mark L (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S249000, C544S118000, C544S258000

Reexamination Certificate

active

07423038

ABSTRACT:
The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders than involve abnormal activation of the Abl, Bcr-abl, Bmx, c-RAF, CSK, Fes, FGFR3, Flt3, GSK3β, IR, JNK1α 1, JNK2α 2, Lck, MKK4, MKK6, p70S6K, PDGFRα, Rsk1, SAPK2α, SAPK2β, Syk and Trkβ kinases.

REFERENCES:
Goldman, et al., N. England J. Med., 344, 14, Apr. 5, 2001.
Ekman, et al., Oncogene (2000) 19, 4151-58.
Xu, et al., J. Biol. Chem., 273, 50, Dec. 11, 1998. 33230-38.
Lopes de Menezes, et al., Clin. Cancer Res. 2005:11 (14), Jul. 15, 2005, 5281-91.
Kawahara, et al., J. Clin. Onc., 2006 ASCO Annual Meeting Proceedings, Part I, vol. 24, No. 18S, Jun. 20, 2006, 13163.
Yoshida, et al., J. Nanochem., 2004, 90, 352-58.
Atlas of Genetics and Cytogenetics in Oncology and Haematology (Sep. 12, 2007).
Wu, et al., Am. J. Pathol., 156, Jun. 6, 2000.
Xie, et al., PNAS, Jul. 31, 2001, 98, 16, pp. 9255-9259.
Khan, et al., Mar. 6, 2007, p. 1277.
“Prevent” (Webster's Comprehensive Dictionary, 1996).
Bhat, et al., J. Neurochem., 2004, 89, 1313-1317.
Martinez, et al., Med. Res. Rev., vol. 22, No. 4, 373-384 (2002).
Gould et al., Curr. Drug Targets, Nov. 7, 2006(11): 1399-409 (Abst.).
Zhao, et al., Schizophr. Res., May 2006; 84(1). Epub Apr. 11, 2006 (Abst.).
Gould, Expert Opin. Ther. Targets, 06-06; 10(3):377-92 (Abst.).
Kwok, et al., Ann. Neurol., vol. 58, No. 6, Dec. 2005, pp. 829-839.
Nadri, et al., Schizo. Res., 71 (2004), 377-382.

Affiliated with

Also associated with

Rating

Compounds and compositions as protein kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds and compositions as protein kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and compositions as protein kinase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3975876